SER: Serina Therapeutics Inc Financial Statements

Balance sheet, income statement, and cash flow statements for Serina Therapeutics Inc (SER).

OverviewDividends

$44.55M Market Cap.

As of 05/08/2025 5:00 PM ET (MRY) • Disclaimer

SER Market Cap. (MRY)


SER Shares Outstanding (MRY)


SER Assets (MRY)


Total Assets

$6.72M

Total Liabilities

$6.22M

Total Investments

$0

SER Income (MRY)


Revenue

$56.00K

Net Income

-$11.14M

Operating Expense

$17.10M

SER Cash Flow (MRY)


CF Operations

-$17.14M

CF Investing

-$22.00K

CF Financing

$13.21M

SER Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$6,724,000 (-25.02%)

$8,968,000 (945.17%)

$858,042 (-72.80%)

$3,154,000 (-19.64%)

Assets Current

$5,676,000 (-25.50%)

$7,619,000 (1288.87%)

$548,575 (-75.44%)

$2,234,000 (-2.15%)

Assets Non-Current

$1,048,000 (-22.31%)

$1,349,000 (335.91%)

$309,467 (-66.36%)

$920,000 (-43.97%)

Goodwill & Intangible Assets

$0 (0%)

$0 (0%)

$0 (0%)

$870,000 (-45.35%)

Shareholders Equity

$641,000 (101.98%)

-$32,294,000 (14.52%)

-$37,778,161 (-219.29%)

-$11,832,000 (-131.27%)

Property Plant & Equipment Net

$1,048,000 (-22.31%)

$1,349,000 (335.91%)

$309,467 (0%)

$0 (0%)

Cash & Equivalents

$3,672,000 (-51.80%)

$7,619,000 (1331.53%)

$532,229 (-16.05%)

$634,000 (20.30%)

Accumulated Other Comprehensive Income

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Deferred Revenue

$0 (0%)

$0 (0%)

$153,500 (0%)

$0 (0%)

Total Investments

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Investments Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Investments Non-Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Inventory

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Receivables

$0 (0%)

$0 (0%)

$0 (0%)

$25,000 (-92.33%)

Trade & Non-Trade Payables

$744,000 (28.28%)

$580,000 (304.64%)

$143,337 (-82.96%)

$841,000 (-51.30%)

Accumulated Retained Earnings (Deficit)

-$44,318,000 (-33.58%)

-$33,177,000 (13.71%)

-$38,446,482 (63.64%)

-$105,748,000 (-8.94%)

Tax Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Tax Liabilities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Debt

$268,000 (-92.22%)

$3,445,000 (89.89%)

$1,814,175 (-86.26%)

$13,202,000 (109.69%)

Debt Current

$0 (0%)

$0 (0%)

$133,924 (-98.12%)

$7,140,000 (198.00%)

Debt Non-Current

$268,000 (-92.22%)

$3,445,000 (105.03%)

$1,680,251 (-72.28%)

$6,062,000 (55.44%)

Total Liabilities

$6,216,000 (27.95%)

$4,858,000 (52.06%)

$3,194,703 (-78.74%)

$15,029,000 (61.24%)

Liabilities Current

$2,366,000 (67.45%)

$1,413,000 (222.83%)

$437,686 (-95.12%)

$8,967,000 (67.39%)

Liabilities Non-Current

$3,850,000 (11.76%)

$3,445,000 (24.95%)

$2,757,017 (-54.52%)

$6,062,000 (52.93%)

SER Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$56,000 (-98.22%)

$3,153,000 (433.05%)

$591,500 (310.76%)

$144,000 (-60.11%)

Cost of Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$19,000 (-26.92%)

Selling General & Administrative Expense

$9,624,000 (147.15%)

$3,894,000 (202.15%)

$1,288,783 (-80.79%)

$6,708,000 (-0.19%)

Research & Development Expense

$7,480,000 (213.23%)

$2,388,000 (51.80%)

$1,573,085 (8.04%)

$1,456,000 (-60.80%)

Operating Expenses

$17,104,000 (172.27%)

$6,282,000 (119.51%)

$2,861,868 (-62.39%)

$7,610,000 (-26.33%)

Interest Expense

$526,000 (-5.73%)

$558,000 (3414.30%)

$15,878 (-98.55%)

$1,097,000 (171.53%)

Income Tax Expense

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$103,000 (-82.15%)

Consolidated Income

-$11,207,000 (-312.70%)

$5,269,000 (296.45%)

-$2,682,108 (69.12%)

-$8,685,000 (20.87%)

Net Income to Non-Controlling Interests

-$66,000 (0%)

$0 (0%)

$0 (0%)

-$10,000 (90.99%)

Net Income

-$11,141,000 (-311.44%)

$5,269,000 (296.45%)

-$2,682,108 (69.08%)

-$8,675,000 (20.16%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

-$11,141,000 (-311.44%)

$5,269,000 (296.45%)

-$2,682,108 (69.08%)

-$8,675,000 (20.16%)

Weighted Average Shares

$7,359,000 (229.26%)

$2,235,000 (4.20%)

$2,145,002 (99.12%)

$1,077,225 (0.58%)

Weighted Average Shares Diluted

$7,359,000 (0.11%)

$7,351,000 (242.70%)

$2,145,002 (99.12%)

$1,077,225 (0.58%)

Earning Before Interest & Taxes (EBIT)

-$10,615,000 (-282.17%)

$5,827,000 (318.55%)

-$2,666,230 (64.82%)

-$7,578,000 (27.56%)

Gross Profit

$56,000 (-98.22%)

$3,153,000 (433.05%)

$591,500 (373.20%)

$125,000 (-62.69%)

Operating Income

-$17,048,000 (-444.84%)

-$3,129,000 (-37.82%)

-$2,270,368 (69.67%)

-$7,485,000 (25.11%)

SER Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

-$22,000 (95.63%)

-$504,000 (-151.38%)

$980,937 (47.29%)

$666,000 (3430.00%)

Net Cash Flow from Financing

$13,212,000 (31.24%)

$10,067,000 (667.26%)

$1,312,070 (-81.89%)

$7,246,000 (21.56%)

Net Cash Flow from Operations

-$17,137,000 (-592.12%)

-$2,476,000 (-19.29%)

-$2,075,624 (73.58%)

-$7,855,000 (-0.49%)

Net Cash Flow / Change in Cash & Cash Equivalents

-$3,947,000 (-155.69%)

$7,087,000 (3160.14%)

$217,383 (281.37%)

$57,000 (103.04%)

Net Cash Flow - Business Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$416,000 (0%)

Net Cash Flow - Investment Acquisitions and Disposals

$0 (0%)

$0 (0%)

$990,619 (296.25%)

$250,000 (0%)

Capital Expenditure

-$22,000 (95.63%)

-$504,000 (-5105.54%)

-$9,682 (0%)

$0 (0%)

Issuance (Repayment) of Debt Securities

$2,875,000 (-71.40%)

$10,052,000 (668.71%)

$1,307,648 (-80.63%)

$6,750,000 (10.33%)

Issuance (Purchase) of Equity Shares

$5,012,000 (33313.33%)

$15,000 (239.21%)

$4,422 (-99.11%)

$496,000 (0%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Share Based Compensation

$2,595,000 (10280.00%)

$25,000 (251.62%)

$7,110 (-99.29%)

$999,000 (9.90%)

Depreciation Amortization & Accretion

$421,000 (59.47%)

$264,000 (24.95%)

$211,284 (61.29%)

$131,000 (-89.56%)

SER Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

100.00% (0.00%)

100.00% (0.00%)

100.00% (15.21%)

86.80% (-6.47%)

Profit Margin

-19894.60% (-12005.80%)

167.10% (136.85%)

-453.40% (92.47%)

-6024.30% (-100.16%)

EBITDA Margin

-18203.60% (-9522.15%)

193.20% (146.55%)

-415.00% (91.98%)

-5171.50% (-102.80%)

Return on Average Equity (ROAE)

131.80% (736.71%)

-20.70% (-250.00%)

13.80% (-85.65%)

96.20% (-73.55%)

Return on Average Assets (ROAA)

-124.70% (-372.27%)

45.80% (134.83%)

-131.50% (57.25%)

-307.60% (-27.21%)

Return on Sales (ROS)

-18955.40% (-10357.25%)

184.80% (140.99%)

-450.80% (91.43%)

-5262.50% (-81.60%)

Return on Invested Capital (ROIC)

-992.30% (-2329.89%)

44.50% (171.20%)

-62.50% (56.42%)

-143.40% (83.12%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0% (0%)

Price to Earnings Ratio (P/E)

-3.32 (-157.84%)

5.74 (136.95%)

-15.53 (-227.66%)

-4.74 (9.60%)

Price to Sales Ratio (P/S)

658.37 (6759.43%)

9.6 (-86.36%)

70.39 (-75.46%)

286.78 (80.81%)

Price to Book Ratio (P/B)

69.5 (15475.88%)

-0.45 (18.41%)

-0.55 (84.15%)

-3.5 (68.79%)

Debt to Equity Ratio (D/E)

9.7 (6564.67%)

-0.15 (-76.47%)

-0.09 (93.31%)

-1.27 (30.30%)

Earnings Per Share (EPS)

-1.51 (-163.98%)

2.36 (288.80%)

-1.25 (84.55%)

-8.09 (20.69%)

Sales Per Share (SPS)

0.01 (-99.43%)

1.41 (411.23%)

0.28 (105.97%)

0.13 (-60.24%)

Free Cash Flow Per Share (FCFPS)

-2.33 (-74.94%)

-1.33 (-37.14%)

-0.97 (86.67%)

-7.29 (0.34%)

Book Value Per Share (BVPS)

0.09 (100.60%)

-14.45 (17.96%)

-17.61 (-60.34%)

-10.98 (-129.94%)

Tangible Assets Book Value Per Share (TABVPS)

0.91 (-77.22%)

4.01 (903.25%)

0.4 (-81.13%)

2.12 (-2.66%)

Enterprise Value Over EBIT (EV/EBIT)

-5 (-266.67%)

3 (121.43%)

-14 (-100.00%)

-7 (-16.67%)

Enterprise Value Over EBITDA (EV/EBITDA)

-5.18 (-292.49%)

2.69 (118.31%)

-14.69 (-110.30%)

-6.99 (-4.24%)

Asset Turnover

0.01 (-97.81%)

0.27 (-5.52%)

0.29 (468.63%)

0.05 (-36.25%)

Current Ratio

2.4 (-55.51%)

5.39 (330.33%)

1.25 (403.21%)

0.25 (-41.55%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

-$17,159,000 (-475.81%)

-$2,980,000 (-42.90%)

-$2,085,306 (73.45%)

-$7,855,000 (-0.23%)

Enterprise Value (EV)

$52,780,800 (222.16%)

$16,383,235 (-54.58%)

$36,073,033 (-30.67%)

$52,029,702 (-15.68%)

Earnings Before Tax (EBT)

-$11,141,000 (-311.44%)

$5,269,000 (296.45%)

-$2,682,108 (69.08%)

-$8,675,000 (20.16%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

-$10,194,000 (-267.36%)

$6,091,000 (348.11%)

-$2,454,946 (67.03%)

-$7,447,000 (19.11%)

Invested Capital

$954,000 (-71.78%)

$3,381,000 (98.61%)

$1,702,302 (-71.07%)

$5,885,000 (114.39%)

Working Capital

$3,310,000 (-46.66%)

$6,206,000 (5496.59%)

$110,889 (101.65%)

-$6,733,000 (-119.03%)

Tangible Asset Value

$6,724,000 (-25.02%)

$8,968,000 (945.17%)

$858,042 (-62.43%)

$2,284,000 (-2.10%)

Market Capitalization

$44,548,800 (204.89%)

$14,611,235 (-30.23%)

$20,943,033 (-49.36%)

$41,353,702 (-27.81%)

Average Equity

-$8,451,250 (66.82%)

-$25,474,750 (-31.23%)

-$19,411,790 (-115.20%)

-$9,020,500 (-201.94%)

Average Assets

$8,930,750 (-22.32%)

$11,496,500 (463.48%)

$2,040,260 (-27.66%)

$2,820,500 (-37.24%)

Invested Capital Average

$1,069,750 (-91.82%)

$13,085,500 (206.64%)

$4,267,326 (-19.26%)

$5,285,000 (329.15%)

Shares

8,891,976 (724.03%)

1,079,080 (0.01%)

1,078,964 (0.02%)

1,078,737 (0.66%)